Form 4: Oncology Institute COO Sells Shares to Cover Tax Obligations

Oncology Institute's Chief Operating Officer, Jeremy Castle, sold 1,130 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Jeremy Castle, the Chief Operating Officer of Oncology Institute, Inc., sold 1,130 shares of common stock on December 3, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• The shares were sold at a volume-weighted average price of $0.16, with individual prices ranging from $0.156 to $0.160.
• Following the transaction, Mr. Castle directly owns 81,330 shares of Oncology Institute stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction for tax purposes, which is neither positive nor negative for the company's overall outlook. The sentiment is neutral to slightly positive as it indicates the executive is receiving stock based compensation.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across publicly traded companies.
• The sale of 1,130 shares is relatively small compared to the total holdings of 81,330 shares, suggesting this is a routine transaction rather than a significant divestment.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is unlikely to be significant given the small volume of shares sold.

Key Dates

Keywords

Oncology Institute, Jeremy Castle, stock sale, restricted stock units, tax obligations, insider trading, Form 4